Sinotherapeutics Inc. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was CNY 109.39 million compared to CNY 127.62 million a year ago. Revenue was CNY 110.77 million compared to CNY 127.85 million a year ago.

Net income was CNY 22.78 million compared to CNY 40.2 million a year ago. Basic earnings per share from continuing operations was CNY 0.05 compared to CNY 0.1 a year ago. Diluted earnings per share from continuing operations was CNY 0.05 compared to CNY 0.1 a year ago.